secwatch.observer — SEC 8-K summary
======================================

Issuer:     Estrella Immunopharma, Inc. (ESLA)
CIK:        0001844417
Form:       8-K
Filed at:   2025-09-26T23:59:59+00:00
Accession:  0001213900-25-092471
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Estrella Immunopharma appoints Jia Dengyao to Board of Directors
----------------------------------------------------------------

- Board appointed Jia Dengyao as director effective September 22, 2025.
- Mr. Jia has not been named to any Board committees as of the filing.
- Company entered into standard indemnification agreement with new director.
- Appointment adds a new independent voice but no other details provided.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1844417/000121390025092471/0001213900-25-092471-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1844417/000121390025092471/ea0259031-8k_estrella.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-092471

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer